Pharmacokinetics of DA-8159, a new erectogenic, administered at 10:00 h versus 22:00 h in rats.

[1]  Yu C. Kim,et al.  Species differences in the formation of DA-8164 after intravenous and/or oral administration of DA-8159, a new erectogenic, to mice, rats, rabbits, dogs and humans. , 2005, Biopharmaceutics & drug disposition.

[2]  Y. Choi,et al.  Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition , 1993, Journal of Pharmacokinetics and Biopharmaceutics.

[3]  W. L. Chiou,et al.  Evaluation of potential causes for the incomplete bioavailability of furosemide: Gastric first-pass metabolism , 1983, Journal of Pharmacokinetics and Biopharmaceutics.

[4]  W. L. Chiou,et al.  Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve , 1978, Journal of Pharmacokinetics and Biopharmaceutics.

[5]  M. Gibaldi,et al.  Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjects , 1977, Journal of Pharmacokinetics and Biopharmaceutics.

[6]  G. Koren,et al.  Study on circadian variation in folate pharmacokinetics. , 2005, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.

[7]  J. Djurhuus,et al.  Pharmacokinetics and pharmacodynamics of desmopressin administered orally versus intravenously at daytime versus night-time in healthy men aged 55–70 years , 2004, European Journal of Clinical Pharmacology.

[8]  W. B. Kim,et al.  Role of human cytochrome P450 3A4 in the metabolism of DA–8159, a new erectogenic , 2004, Xenobiotica; the fate of foreign compounds in biological systems.

[9]  A. Nava,et al.  Circadian variation of cyclosporine A in renal transplanted patients. , 2004, Revista alergia Mexico.

[10]  G. Ahn,et al.  Efficacy of DA-8159, a new PDE5 inhibitor, for inducing penile erection in rabbits with acute spinal cord injury , 2003, International Journal of Impotence Research.

[11]  Yu C. Kim,et al.  Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects. , 2003, Journal of pharmaceutical sciences.

[12]  Tetsuro Kato,et al.  Chronopharmacokinetics of Tacrolimus in Kidney Transplant Recipients: Occurrence of Acute Rejection , 2003, Journal of clinical pharmacology.

[13]  W. Kim,et al.  DA-8159, a new PDE5 Iihibitor, induces penile erection in conscious and acute spinal cord injured rabbits. , 2003, European urology.

[14]  M. Son,et al.  Mechanism of erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159 , 2002, Archives of pharmacal research.

[15]  So H. Kim,et al.  Determination of a new phosphodiesterase V inhibitor, DA-8159, in plasma and urine by high-performance liquid chromatography. , 2002, Journal of pharmaceutical and biomedical analysis.

[16]  Won Bae Kim,et al.  In vitro metabolism of a novel phosphodiesterase-5 inhibitor DA-8159 in rat liver preparations using liquid chromatography/electrospray mass spectrometry. , 2002, Biomedical chromatography : BMC.

[17]  G. Milano,et al.  Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics , 2002, Chronobiology international.

[18]  J. Kwon,et al.  Factors influencing the protein binding of a new phosphodiesterase V inhibitor, DA-8159, using an equilibrium dialysis technique. , 2000, Biopharmaceutics & drug disposition.

[19]  D. Türck,et al.  Steady-state pharmacokinetics of lithium in healthy volunteers receiving concomitant meloxicam. , 2000, British journal of clinical pharmacology.

[20]  A. Reinberg.  Concepts in chronopharmacology. , 1992, Annual review of pharmacology and toxicology.

[21]  B. Hecquet,et al.  [Mechanisms and perspectives in clinical chronopharmacokinetics]. , 1989, Therapie.

[22]  B. Bruguerolle.  [Recent data in chronopharmacokinetics]. , 1987, Pathologie-biologie.

[23]  W. Jusko,et al.  Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis. , 1984, Journal of pharmaceutical sciences.

[24]  T. Guentert.  Time-Dependence in Benzodiazepine Pharmacokinetics Mechanisms and Clinical Significance , 1984, Clinical pharmacokinetics.

[25]  A. Reinberg,et al.  Circadian Changes of Drug Disposition in Man , 1982, Clinical pharmacokinetics.

[26]  T. Guentert,et al.  Comparison of Equilibrium Times in Dialysis Experiments Using Spiked Plasma or Spiked Buffer , 1982 .

[27]  W. L. Chiou.  New calculation method of mean total body clearance of drugs and its application to dosage regimens. , 1980, Journal of pharmaceutical sciences.

[28]  W. L. Chiou.  New calculation method for mean apparent drug volume of distribution and application to rational dosage regimens. , 1979, Journal of pharmaceutical sciences.